# Immunovant, Inc.: Form 8-K, filed Sep 3, 2026

- Company: [Immunovant, Inc.](/companies/imvt.md) (CIK 1764013)
- Form: 8-K
- Filed: 2026-09-03
- Accepted by EDGAR: Sep 3, 2026, 17:05 ET
- Period: 2026-09-02
- Accession: 0001764013-26-000106
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1764013/000176401326000106/imvt-20260902.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1764013/000176401326000106/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1764013/000176401326000106/imvt-20260902.htm

Filed Sep 3, 2026.
Source: SEC EDGAR, the filing index for accession 0001764013-26-000106. Last ingested by Listed: Oct 30, 2026, 16:48 ET. No prices; not investment advice.